Insider · CIK 0001934008

Murdock Hunter R.

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001934008

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-21	AXSMAxsome Therapeutics, Inc. · Performance Stock UnitsA Award	General Counsel	AAward	+7,224 sh	—	—	7,224
2026-02-26	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	General Counsel	AAward	+16.4K sh	—	—	16,385
2025-06-23	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+6,014 sh	$29.91	+$180K	6,014
2025-06-23	AXSMAxsome Therapeutics, Inc.S Sale	General Counsel	SSale	−6,014 sh	$100.12	−$602K	0
2025-06-23	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	General Counsel	MExercise/Conversion	−6,014 sh	—	—	16,369
2025-06-20	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+7,500 sh	$29.91	+$224K	7,500
2025-06-20	AXSMAxsome Therapeutics, Inc.S Sale	General Counsel	SSale	−7,500 sh	$102.47	−$769K	0
2025-06-20	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	General Counsel	MExercise/Conversion	−7,500 sh	—	—	22,383
2025-06-18	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+7,500 sh	$29.91	+$224K	7,500
2025-06-18	AXSMAxsome Therapeutics, Inc.S Sale	General Counsel	SSale	−7,500 sh	$100.90	−$757K	0
2025-06-18	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	General Counsel	MExercise/Conversion	−7,500 sh	—	—	29,883
2025-06-17	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+7,500 sh	$29.91	+$224K	7,500
2025-06-17	AXSMAxsome Therapeutics, Inc.S Sale	General Counsel	SSale	−7,500 sh	$100.26	−$752K	0
2025-06-17	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	General Counsel	MExercise/Conversion	−7,500 sh	—	—	37,383
2025-06-16	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+7,500 sh	$29.91	+$224K	7,500
2025-06-16	AXSMAxsome Therapeutics, Inc.S Sale	General Counsel	SSale	−7,500 sh	$102.42	−$768K	0
2025-06-16	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	General Counsel	MExercise/Conversion	−7,500 sh	—	—	44,883
2025-02-24	AXSMAxsome Therapeutics, Inc. · Performance Stock UnitsA Award	General Counsel	AAward	+7,740 sh	—	—	7,740
2025-02-21	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	General Counsel	AAward	+7,816 sh	—	—	7,816
2025-02-21	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	General Counsel	AAward	+7,740 sh	—	—	7,740
2024-02-27	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	General Counsel	AAward	+23.6K sh	—	—	23,593
2024-02-27	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	General Counsel	AAward	+13K sh	—	—	12,956
2023-03-02	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	General Counsel	AAward	+29.8K sh	—	—	29,773
2023-03-02	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	General Counsel	AAward	+16.9K sh	—	—	16,883

Recent filings

Accepted (ET)
Apr 234
Murdock Hunter R.0001193125-26-174411
SEC(opens sec.gov)
Feb 274
Murdock Hunter R.0001193125-26-083607
SEC(opens sec.gov)
Jun 234
Murdock Hunter R.0000950170-25-089158
SEC(opens sec.gov)
Jun 184
Murdock Hunter R.0000950170-25-088105
SEC(opens sec.gov)
Feb 254
Murdock Hunter R.0000950170-25-027072
SEC(opens sec.gov)

Companies

Axsome Therapeutics, Inc.General CounselAXSM

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007